部分凝血活酶时间
凝血时间
凝血病
新鲜冰冻血浆
医学
复苏
凝血酶原时间
凝血活酶
血栓弹性成像
多发伤
凝结
凝血时间激活
麻醉
止血
失血性休克
凝血因子
休克(循环)
堆积红细胞
内科学
外科
血小板
输血
体外循环
作者
Nicholas J. Spoerke,Philbert Y. Van,Jerome A. Differding,Karen A. Zink,S. David Cho,Patrick Müller,Zülküf Karahan,Jill L. Sondeen,John B. Holcomb,Martin A. Schreiber
出处
期刊:Journal of Trauma-injury Infection and Critical Care
[Lippincott Williams & Wilkins]
日期:2010-11-01
卷期号:69 (5): 1054-1061
被引量:21
标识
DOI:10.1097/ta.0b013e3181f9912a
摘要
Background: Hemorrhage and coagulopathy are major contributors to death after trauma. The contribution of red blood cells (RBCs) in correcting coagulopathy is poorly understood. Current methods of measuring coagulopathy may fail to accurately characterize in vivo clotting. We aimed to determine the effect of RBCs on clotting parameters by comparing resuscitation regimens containing RBCs and plasma with those containing plasma alone. Methods: Thirty-two Yorkshire swine were anesthetized, subjected to a complex model of polytrauma and hemorrhagic shock, and resuscitated with either fresh frozen plasma, lyophilized plasma (LP), or 1:1 ratios of fresh frozen plasma:packed RBC (PRBC) or LP:PRBC. Activated clotting time, prothrombin time, partial thromboplastin time, and thrombelastography (TEG) were performed at 1 hour, 2 hours, 3 hours, and 4 hours after resuscitation. Results: Animals treated with 1:1 LP:PRBC had less blood loss than the other groups (p < 0.05). The activated clotting time was shorter in the 1:1 groups when compared with the pure plasma groups at all time points (p < 0.05). The 1:1 groups had shorter TEG R times (time to onset of clotting) at 1 hour, 3 hours, and 4 hours compared with pure plasma groups (p < 0.05). Other TEG parameters did not differ between groups. Partial thromboplastin time was shorter in the pure plasma groups than the 1:1 groups at all time points (p < 0.05). Conclusions: Whole blood assays reveal that RBCs accelerate the onset of clot formation. Coagulation assays using spun plasma underestimate the effect of RBCs on clotting and do not completely characterize clot formation.
科研通智能强力驱动
Strongly Powered by AbleSci AI